$GCTKAug 21, 2026, 12:00 PMAI processed
Lōkahi expands ai2 Futures Lab network with renewed University of Georgia collaboration
AI Summary
Lōkahi Therapeutics (a Glucotrack, Inc. subsidiary - NASDAQ: GCTK) renewed its participation with the University of Georgia Student Industry Fellows Program to continue sourcing and evaluating overlooked therapeutic assets through its ai2 Futures Lab. The program is a capital-efficient origination channel — in year one it engaged 64 students, identified more than 45 potential acquisition assets and advanced several into active pipeline discussions, expanding Lōkahi's sourcing reach and analytical capacity.
Positives
- Renewed University of Georgia participation expands Lōkahi’s nationwide ai² Futures Lab network
- Year-one output: 64 students engaged and >45 potential acquisition assets identified
- Several candidate assets advanced into active pipeline discussions, validating the sourcing model
Negatives
- Identified assets are potential opportunities; no acquisitions, transaction terms, or guaranteed outcomes announced
- Operational progress depends on Glucotrack’s ability to raise additional capital
- Press release discloses forward-looking risks and uncertainty around integration and advancement of sourced assets